4.7 Article

Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions

Related references

Note: Only part of the references are listed.
Article Oncology

Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort

Hiten D. Patel et al.

Summary: Men with prior negative prostate biopsies have a lower risk of being diagnosed with prostate cancer, and decision curve analyses suggest that many unnecessary biopsies can be avoided by using the PLUM models or a PI-RADS 4 cutoff.

CANCER (2022)

Article Urology & Nephrology

Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible Lesions

Hiten D. Patel et al.

Summary: This study compares the effectiveness of systematic biopsy, magnetic resonance imaging-targeted biopsy, and combined biopsy in detecting prostate cancer. The results show that combined biopsy can improve the detection rate of clinically-significant PCa without increasing the diagnosis rate of GG1 PCa. Targeted biopsy performs better in patients with a prior negative biopsy, but the advantages of combined biopsy are maintained regardless of biopsy history.

JOURNAL OF UROLOGY (2022)

Article Oncology

The stanford prostate cancer calculator: Development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer

Nancy N. Wang et al.

Summary: The study aimed to develop and validate a nomogram combining PIRADS scores and clinical data to predict the probability of prostate cancer detection in men. Results showed that the nomogram, named SPCC, provided stronger predictive accuracy than using PSA density or PIRADS alone, with robust AUC values in external validation.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Urology & Nephrology

Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions

Bashir Al Hussein Al Awamlh et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Review Oncology

MRI in active surveillance: a critical review

Vasilis Stavrinides et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2019)

Article Urology & Nephrology

Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists

Geoffrey A. Sonn et al.

EUROPEAN UROLOGY FOCUS (2019)

Article Medicine, General & Internal

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

V Kasivisvanathan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Urology & Nephrology

Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy

Marc A. Bjurlin et al.

UROLOGIC CLINICS OF NORTH AMERICA (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Risk Stratification Among Men With Prostate Imaging Reporting and Data System Version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?

Ely R. Felker et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2017)

Article Urology & Nephrology

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2

Jeffrey C. Weinreb et al.

EUROPEAN UROLOGY (2016)

Review Urology & Nephrology

Overdiagnosis and Overtreatment of Prostate Cancer

Stacy Loeb et al.

EUROPEAN UROLOGY (2014)

Article Biochemical Research Methods

pROC: an open-source package for R and S plus to analyze and compare ROC curves

Xavier Robin et al.

BMC BIOINFORMATICS (2011)